心臟節律器市場規模、佔有率和成長分析：按產品類型、最終用戶、應用、植入方法和地區分類－2026-2033年產業預測

2024 年全球心臟節律器市場價值為 1,467.5 億美元，預計到 2033 年將從 2025 年的 1,558.5 億美元成長至 2,521.7 億美元，在預測期（2026-2033 年）內複合年成長率為 6.2%。

全球心臟節律器市場正受到人口老化和心血管疾病發生率上升的顯著影響。預測顯示，房室傳導阻滯病例將大幅增加，其中絕大多數為完全性房室傳導阻滯，佔永久性心律調節器適應症的大部分。終生發生心房顫動的風險也在上升，擴大了符合心律調節器治療條件的患者族群。尤其值得注意的是，相當一部分心律調節器植入手術是在85歲及以上的老年患者中進行的，這凸顯了對有效老年護理日益成長的需求。此外，無導線和磁振造影相容型心律調節器等技術進步因其更高的安全性、耐用性和易用性而備受關注。Medtronic的「Micra」和雅培公司的「AVEIR DR」等創新產品正是這一趨勢的例證，並推動了市場的強勁成長。

全球心臟心律調節器市場的成長要素

全球心臟心律調節器市場的主要促進因素之一是心血管疾病盛行率的上升和全球人口老化。隨著心臟相關疾病的日益普遍，對心臟心律調節器等先進醫療設備的需求顯著成長。心律調節器設計和功能的持續技術進步進一步推動了這項需求的成長，改善了患者的治療效果和舒適度。此外，預防醫學意識的提高以及發展中地區醫療服務可近性的改善也促進了市場擴張，因為越來越多的患者正在尋求治療心率的解決方案。

全球心臟節律器市場的限制因素

全球心臟心律調節器市場的主要限制因素之一是心律調節器本身及其植入手術的高昂成本。這些成本會限制人們獲得這項關鍵醫療技術的機會，尤其是在醫療預算有限的中低收入地區。此外，手術的複雜性和相關風險也會成為患者和醫療服務提供者接受心律調節器植入的障礙。同時，手術併發症的風險以及持續監測和維護的需求也會顯著阻礙心臟節律器的廣泛應用，並可能影響整體市場成長。

全球心臟心律調節器市場趨勢

全球心臟節律器市場正經歷著向遠端監測和遠端心臟病學解決方案整合的顯著轉變。隨著數位醫療的普及，無線連接的心律調節器日益常見，從而實現以患者為中心的醫療服務。這一發展趨勢使醫療專業人員能夠即時存取患者數據，有助於早期發現併發症，減少患者就診次數，並最終提高整體患者照護品質。這一趨勢表明，整個行業正在積極擁抱先進技術，凸顯了向以價值為導向的醫療模式的轉變，該模式優先考慮慢性病管理和患者參與。對遠端功能日益成長的需求將重新定義心臟護理的提供方式。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢
• 案例研究

全球心臟節律器市場規模：依產品類型分類

• 心律調節器的類型
  • 單腔心律調節器
  • 雙腔心律調節器
  • 雙心室節律器
  • 體外心律調節器
• 科技
  • 核磁共振相容型心臟節律器
  • 傳統心律調節器
• 產品類型
  • 植入式心臟節律器
  • 體外心律調節器

全球心臟節律器市場規模：依最終用戶分類

• 醫院和診所
• 門診手術中心
• 居家醫療環境

全球心臟節律器市場規模：按應用領域分類

• 心搏過緩
• 心房顫動
• 心臟傳導阻滯
• 心律不整
• 長QT間期症候群
• 鬱血性心臟衰竭
• 其他

全球心臟節律器市場規模：依植入類型分類

• 經靜脈植入
• 心外膜植入
• 無鉛種植

全球心臟節律器市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Medtronic
• Abbott
• Boston Scientific
• Biotronik
• LivaNova
• Zoll Medical Corporation
• Sorin Group
• MicroPort Scientific Corporation
• OSYPKA MEDICAL
• St. Jude Medical
• Shree Pacetronix Ltd.
• Cardiovascular Systems, Inc.
• Avinger, Inc.
• Neovasc Inc.
• AngioDynamics, Inc.
• Inari Medical, Inc.
• Acutus Medical, Inc.
• Imricor Medical Systems, Inc.
• B. Braun Melsungen AG
• Edwards Lifesciences Corporation

結論與建議

Global Cardiac Pacemaker Market size was valued at USD 146.75 Billion in 2024 and is poised to grow from USD 155.85 Billion in 2025 to USD 252.17 Billion by 2033, growing at a CAGR of 6.2% during the forecast period (2026-2033).

The global cardiac pacemaker market is significantly influenced by the aging population and the increasing incidence of cardiovascular diseases. Projections indicate a notable rise in atrioventricular block cases, with complete heart block being responsible for the majority of permanent pacemaker indications. The lifetime risk of atrial fibrillation is also rising, expanding the pool of candidates for pacing therapy. Notably, a significant proportion of pacemaker implants are performed on patients aged 85 and older, emphasizing the growing need for effective geriatric care. Additionally, advancements in technology, such as leadless and MRI-conditional pacemakers, are gaining traction due to their improved safety, longevity, and user-friendliness. Innovations like Medtronic's Micra and Abbott's AVEIR DR exemplify this trend, fueling robust market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Pacemaker Market Segments Analysis

Global Cardiac Pacemaker Market is segmented by Product, End User, Application, Implantation Type and region. Based on Product, the market is segmented into Pacemaker Type, Technology and Product Type. Based on End User, the market is segmented into Hospitals and Clinics, Ambulatory Surgery Centers and Home Care Settings. Based on Application, the market is segmented into Bradycardia, Atrial Fibrillation, Heart Block, Arrhythmias, Long QT Syndrome, Congestive Heart Failure and Others. Based on Implantation Type, the market is segmented into Transvenous Implantation, Epicardial Implantation and Leadless Implantation. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Pacemaker Market

One of the key market drivers for the global cardiac pacemaker market is the increasing prevalence of cardiovascular diseases, coupled with the rising aging population worldwide. As heart-related conditions become more common, the demand for advanced medical devices, such as pacemakers, is growing significantly. This uptick is further fueled by continuous technological advancements in pacemaker design and functionality, which enhance patient outcomes and comfort. Additionally, increasing awareness of preventive healthcare and improved access to healthcare services in developing regions are contributing to the market's expansion, as more patients seek solutions for heart rhythm disorders.

Restraints in the Global Cardiac Pacemaker Market

One of the primary market restraints for the global cardiac pacemaker market is the high cost associated with pacemaker devices and their implantation procedures. These expenses can limit access to such crucial medical technology, particularly in low to middle-income regions where healthcare budgets are constrained. Additionally, the complexity of surgical procedures and the associated risks can deter both patients and healthcare providers from opting for pacemaker implantation. Furthermore, the potential for surgical complications and the requirement for ongoing monitoring and maintenance may pose significant barriers to the widespread adoption of cardiac pacemakers, impacting overall market growth.

Market Trends of the Global Cardiac Pacemaker Market

The Global Cardiac Pacemaker market is experiencing a notable shift towards the integration of remote monitoring and telecardiology solutions. As digital health gains traction, wireless connected pacemakers are becoming increasingly prevalent, allowing for more patient-centric care. This evolution enables healthcare providers to access real-time patient data, facilitating the early detection of complications, reducing the need for hospital visits, and ultimately improving the overall quality of patient care. The trend is indicative of an industry-wide embrace of advanced technologies, underscoring the transition towards value-based healthcare models that prioritize chronic care management and patient engagement. This growing preference for remote capabilities is set to redefine the landscape of cardiac care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape
• Case Studies

Global Cardiac Pacemaker Market Size by Product & CAGR (2026-2033)

• Market Overview
• Pacemaker Type
  • Single Chamber Pacemakers
  • Dual Chamber Pacemakers
  • Biventricular Pacemakers
  • External Pacemakers
• Technology
  • MRI Compatible Pacemakers
  • Conventional Pacemakers
• Product Type
  • Implantable Pacemakers
  • External Pacemakers

Global Cardiac Pacemaker Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals and Clinics
• Ambulatory Surgery Centers
• Home Care Settings

Global Cardiac Pacemaker Market Size by Application & CAGR (2026-2033)

• Market Overview
• Bradycardia
• Atrial Fibrillation
• Heart Block
• Arrhythmias
• Long QT Syndrome
• Congestive Heart Failure
• Others

Global Cardiac Pacemaker Market Size by Implantation Type & CAGR (2026-2033)

• Market Overview
• Transvenous Implantation
• Epicardial Implantation
• Leadless Implantation

Global Cardiac Pacemaker Market Size & CAGR (2026-2033)

• North America (Product, End User, Application, Implantation Type)
  • US
  • Canada
• Europe (Product, End User, Application, Implantation Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User, Application, Implantation Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User, Application, Implantation Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User, Application, Implantation Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoll Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sorin Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OSYPKA MEDICAL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• St. Jude Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shree Pacetronix Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiovascular Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avinger, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neovasc Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inari Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Acutus Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imricor Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Edwards Lifesciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations